Tafinlar

Tafinlar (Dabrafenib) is an oral prescription medication used to treat certain cancers. It belongs to a class of drugs known as kinase inhibitors, designed to slow or stop cancer cell growth. This medication is not available over the counter. Consult a healthcare provider for suitability.

Tafinlar is primarily used to treat melanoma, a type of skin cancer, when the disease has spread to other parts of the body or cannot be removed by surgery. It may also be prescribed for non-small cell lung cancer and anaplastic thyroid cancer in specific cases. This drug targets cancer cells with a particular genetic mutation. It is used under medical supervision.

Tafinlar works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow the progression of the disease. Patients may experience effects such as fatigue, fever, or chills as their body adjusts to the medication. These effects vary by individual and should be monitored by a healthcare provider.

Tafinlar should be taken exactly as prescribed by a doctor. Keep the medication in a cool, dry place away from direct sunlight. Avoid crushing or splitting capsules unless instructed. Report any unusual symptoms, such as severe rash or fever, to a healthcare provider promptly. Do not start or stop other medications without consulting a doctor.

Tafinlar can interact with other drugs, including certain antibiotics, antifungals, and herbal supplements like St. John’s Wort. These interactions may affect how the medication works or increase side effects. Alcohol and grapefruit products may also interact with Dabrafenib. Always inform your healthcare provider about all medications you are taking.